ArticleCells2021

Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling.

Woo-Jin Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.